Document Type


Publication Date



This article is the authors' final version prior to publication in Clinical and Translational Science, May 2020, Pages 758-762.

The published version is available at Copyright © Lam et al.


Doravirine (DOR) is a non‐nucleoside reverse transcriptase inhibitor indicated for the treatment of human immunodeficiency virus‐1 (HIV‐1). Its use in combination with rifapentine (RPT), an anti‐tuberculosis antibiotic, may reduce the exposure of DOR compromising viral suppression in those living with HIV‐1 co‐infected with tuberculosis. We conducted a prospective, phase I, open label, two‐period, fixed sequence, drug interaction study to evaluate the effect of once‐weekly RPT and isoniazid (INH) on the pharmacokinetics of DOR in healthy volunteers. DOR 100 mg was administered alone twice‐daily for 4 days in period 1. In period 2, once‐weekly RPT+INH was co‐administered with multiple doses of DOR 100 mg twice‐daily for study days 7, 14, and 21. Plasma was obtained for DOR pharmacokinetics when given alone and co‐administered with RPT+INH. Eleven healthy volunteers enrolled and completed the study. The geometric mean ratios and 90% confidence intervals for DOR AUC0‐12 and C12 in the presence of RPT+INH compared to DOR alone were 0.71 (0.60‐0.85) and 0.69 (0.54‐0.89), respectively. Although exposures were moderately reduced in the presence of RPT+INH, trough DOR values were within the concentration range associated with virological suppression. These results demonstrate that a modest decrease in doravirine exposure would unlikely be clinically relevant in a virally suppressed patient co‐administered once‐weekly RPT+INH.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

PubMed ID






To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.